文献速递痛风与晶体性关节病

血脂异常、饮酒与肥胖是降尿酸治疗中尿酸控制不佳的主要相关因素

Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-03-23

该横断面研究纳入1995例接受降尿酸治疗的痛风患者,仅22.3%达到血清尿酸≤6.0 mg/dl的目标。多因素分析显示,低高密度脂蛋白胆固醇、高总胆固醇、腰围增加和饮酒与尿酸控制不佳独立相关。识别这些因素有助于医生预判难以达标的痛风患者。

要点

  • 接受降尿酸治疗的痛风患者中仅22.3%达到血清尿酸≤6.0 mg/dl的目标。
  • 血脂异常、腹型肥胖和饮酒是尿酸控制不佳的主要相关因素。
  • 达标患者既往一年痛风发作次数低于未达标患者。

核心结论

  • 血脂异常、腹型肥胖和饮酒是与降尿酸治疗反应不佳相关的主要因素。

研究设计与样本

  • 横断面研究纳入1995例正在接受降尿酸治疗的初级保健成人痛风患者,比较达标(血清尿酸≤6.0 mg/dl)与未达标(>6.0 mg/dl)两组的临床特征。

主要发现

  • 1995例接受降尿酸治疗的患者中仅445例(22.3%)达到血清尿酸≤6.0 mg/dl的目标。
  • 达标患者既往一年痛风发作次数低于未达标患者(均值±标准差 1.7±1.4 versus 2.1±1.4;P<0.0001)。
  • 多因素分析中与尿酸控制不佳相关的主要因素包括低高密度脂蛋白胆固醇水平(校正OR 0.5[95%CI 0.26-0.96];P=0.04)、高总胆固醇水平(OR 1.83[95%CI 1.29-2.60];P=0.0007)、腰围增加(OR 1.55[95%CI 1.11-2.13];P=0.008)和饮酒(OR 1.52[95%CI 1.15-2.00];P=0.003)。

关键数值与推荐

  • 血清尿酸控制目标为≤6.0 mg/dl,未达标定义为>6.0 mg/dl。

临床怎么用

  • 对接受降尿酸治疗的痛风患者,应评估血脂、腰围和饮酒情况以识别尿酸达标可能性较低者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In real life, in a substantial proportion of gouty patients receiving urate-lowering therapy (ULT), urate levels are not maintained below the target of 6.0 mg/dl. We aimed to search for factors associated with poor control of serum uric acid (UA) levels in a large population of patients with gout receiving ULT. METHODS: This cross-sectional study involved adults with gout in primary care who were receiving ULT. Demographics, gout history, comorbidities, lifestyle, clinical factors, concomitant treatments, and laboratory data were compared in well-controlled gout (serum UA ≤6.0 mg/dl) versus poorly controlled gout (serum UA >6.0 mg/dl) on univariate and multivariate analyses. RESULTS: Among the 1,995 patients receiving ULT, only 445 (22.3%) had reached the target of 6.0 mg/dl serum UA. Such patients had a lower rate of gout flares within the previous year than patients without the target (mean ± SD 1.7 ± 1.4 versus 2.1 ± 1.4; P < 0.0001). The main factors associated with poor serum UA level control in multivariate analysis were low high-density lipoprotein cholesterol level (adjusted odds ratio [OR] 0.5 [95% confidence interval (95% CI) 0.26-0.96]; P = 0.04), high total cholesterol level (OR 1.83 [95% CI 1.29-2.60]; P = 0.0007), increased waist circumference (OR 1.55 [95% CI 1.11-2.13]; P = 0.008), and alcohol consumption (OR 1.52 [95% CI 1.15-2.00]; P = 0.003). CONCLUSION: Dyslipidemia, abdominal obesity, and alcohol consumption are the main factors associated with a poor response to ULT. Knowledge of these factors might help physicians identify cases of gout that may be less likely to achieve target urate level.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Latourte A, Bardin T, Clerson P, et al. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy. Arthritis Care Res (Hoboken). 2018. PMID: 28834411. doi:10.1002/acr.23347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。